5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 98.57▼ | 98.30▲ | 98.11▲ | 96.87▲ | 99.34▼ |
MA10 | 98.60▼ | 97.86▲ | 97.10▲ | 96.41▲ | 102.70▼ |
MA20 | 98.44▼ | 97.01▲ | 97.35▲ | 98.89▼ | 106.12▼ |
MA50 | 97.98▲ | 97.20▲ | 96.49▲ | 103.57▼ | 103.41▼ |
MA100 | 97.02▲ | 96.56▲ | 98.13▲ | 106.00▼ | 98.91▼ |
MA200 | 97.34▲ | 98.47▼ | 100.64▼ | 103.47▼ | 86.93▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.042▼ | 0.214▲ | 0.174▲ | 0.156▲ | -1.474▼ |
RSI | 52.122▲ | 62.236▲ | 58.385▲ | 46.135▼ | 43.107▼ |
STOCH | 46.962 | 92.335▲ | 84.741▲ | 37.206 | 16.275▼ |
WILL %R | -83.851▼ | -16.708▲ | -16.708▲ | -48.455 | -77.459▼ |
CCI | -69.350 | 97.980 | 117.088▲ | -4.205 | -129.436▼ |
Friday, March 24, 2023 04:18 AM
BioLineRx Ltd. (NASDAQ:BLRX) Q4 2022 Earnings Call Transcript March 22 ... pharmacoeconomic study of Motixafortide at the 64th American Society of Hematology, the ASH Annual Meeting which was held in ...
|
Friday, March 24, 2023 04:15 AM
Q4 2022 Earnings Call Transcript March 20, 2023 Nicole Leber: Welcome to our fourth quarter and full-year 2022 earnings call. I will be your host for today’s call. As a reminder, this call is being ...
|
Thursday, March 23, 2023 01:44 PM
APTIVATE Expansion Trial of Tuspetinib as Single Agent in Relapsed/Refractory AML Patients is Up and Running; Initiated Enrollment of Combination Treatment Arm with Venetoclax ─ ─ RAS Mutated AML ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
24/03/23 | 95.10 | 99.09 | 94.95 | 98.38 | 592,700 |
23/03/23 | 96.52 | 98.05 | 95.22 | 95.63 | 367,900 |
22/03/23 | 96.94 | 99.36 | 96.40 | 96.41 | 613,500 |
21/03/23 | 97.98 | 98.45 | 97.06 | 97.23 | 380,100 |
20/03/23 | 95.91 | 96.73 | 95.72 | 96.68 | 355,300 |
17/03/23 | 95.71 | 95.82 | 94.84 | 95.00 | 665,700 |
16/03/23 | 94.76 | 96.76 | 94.21 | 96.39 | 460,983 |
15/03/23 | 95.63 | 96.81 | 94.21 | 95.36 | 549,055 |
14/03/23 | 97.00 | 99.48 | 95.99 | 97.69 | 508,596 |
13/03/23 | 96.09 | 96.99 | 95.10 | 95.35 | 387,643 |
|
|
||||
|
|
||||
|
|